- https://doi.org/10.3969/j.issn.1002-2694.2021.00.094
Overview of SARS-CoV-2 viral load and its clinical value
Translate Article 
Take Notes During the unprecedented COVID-19 pandemic, detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral nucleic acids in diverse specimens from patients, people with suspected infection and their close contacts has been widely implemented in infection confirmation, patient management and transmission prevention. Viral nucleic acid detection results not only reflect the infection status in suspected cases, but also are used to quantify positive specimens in most assays. For most viral diseases, viral loads are theoretically associated with potent infectivity and prognostic outcomes in patients. In this review, the principles and characteristics of SARS-CoV-2 viral load detected by real time reverse transcription PCR (RT-PCR) and digital PCR are summarized. The distribution and dynamic changes in viral load in humans are discussed, and the correlations of viral load with disease severity, infectivity and prognostic indicators are analyzed. The comprehensive descriptions of COVID-19 characterization will help guide current practices in infection control, patient treatment and management, and combating the ongoing COVID-19 pandemic.
- Discussion
147 - 10.1016/j.jinf.2020.06.059
- Jun 25, 2020
- Journal of Infection
Viral dynamics of SARS-CoV-2 in saliva from infected patients
- Research Article
- 4
- 10.1016/j.ajodo.2020.08.010
- Sep 21, 2020
- American Journal of Orthodontics and Dentofacial Orthopedics
COVID-19: What do we know?
- Research Article
- 8
- 10.1097/jom.0000000000002238
- Apr 23, 2021
- Journal of Occupational & Environmental Medicine
SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers.
- Research Article
- 16
- 10.31635/ccschem.020.202000322
- Jul 10, 2020
- CCS Chemistry
Coronavirus disease 2019 (COVID-19) is caused by a novel strain of coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused a global pandemic rapidly s...
- Discussion
- 6
- 10.1016/j.ijid.2021.01.049
- Jan 27, 2021
- International Journal of Infectious Diseases
In response to: Multiple assays in a real-time RT-PCR severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
- Research Article
- 8
- 10.1111/ajt.16464
- Feb 18, 2021
- American Journal of Transplantation
Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic.
- Research Article
- 4
- 10.1097/00029330-200809010-00025
- Sep 1, 2008
- Chinese Medical Journal
Pathogenesis of severe acute respiratory syndrome
- Discussion
- 4
- 10.1053/j.gastro.2020.05.084
- Jun 13, 2020
- Gastroenterology
SARS-CoV-2 RNA Detection in Gastrointestinal Sample Displays Poor Performance
- Discussion
- 16
- 10.1016/j.jinf.2020.11.023
- Nov 26, 2020
- The Journal of Infection
Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR
- Discussion
- 29
- 10.4103/ijmr.ijmr_2235_20
- May 1, 2020
- Indian Journal of Medical Research
Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection.
- Research Article
- 6
- 10.1111/bjh.17517
- Jun 7, 2021
- British Journal of Haematology
Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
- Front Matter
- 2
- 10.1016/j.adaj.2021.12.011
- Jan 24, 2022
- Journal of the American Dental Association (1939)
Severe acute respiratory syndrome coronavirus 2 screening to augment dental office and patient safety
- Research Article
- 2
- 10.1128/spectrum.01369-23
- Nov 1, 2023
- Microbiology Spectrum
Viral load quantification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a critical measure for monitoring clinical responses of patients with COVID-19. The cobas SARS-CoV-2 Duo (Roche Molecular Systems, Inc.) uses the cobas 6800/8800 platform and is an automated real-time reverse transcription PCR (RT-PCR) assay for the qualitative detection of SARS-CoV-2 RNA (ORF1a and ORF1a/b non-structural regions) in nasal and nasopharyngeal specimens. This assay also performs quantitation of the SARS-CoV-2 RNA level in the collected specimen. The precision, accuracy, and linearity of the cobas SARS-CoV-2 Duo test were assessed and correlated with the cycle threshold (Ct) value of the cobas SARS-CoV-2 assay, and the cobas Liat SARS-CoV-2 and influenza A/B assay (Inf A/B) (cobas Liat) in 201 clinical nasopharyngeal swab specimens. The analytical measurement range of the cobas SARS-CoV-2 Duo has been verified to be 1.0E + 02 IU/mL to 1.0E + 09 IU/mL. The between- and within-run precision evaluation and the linearity results (R 2 = 0.9961) of the cobas SARS-CoV-2 Duo were acceptable based on the verification criteria. A total of 201 nasopharyngeal specimens were evaluated. The positive, negative, and total agreements between the cobas SARS-CoV-2 Duo and the cobas SARS-CoV-2 assay were 93.5% (157 of 168), 75% (33 of 44), and 92.5% (186 of 201), respectively. The qualitative results (Ct values) from the cobas SARS-CoV-2 and the cobas Liat demonstrated good agreement with the quantitative results from the cobas SARS-CoV-2 Duo assay. In conclusion, the diagnostic performance of the cobas SARS-CoV-2 Duo assay is appropriate. It is a precise, accurate, and sensitive method for the detection of SARS-CoV-2 RNA and is comparable to two qualitative assays. IMPORTANCE Quantitative SARS-CoV-2 tests for viral load are necessary to guide patient treatment, as well as to determine infection control measures and policies. Although the real-time RT-PCR assays can report the Ct value to estimate the viral load, there are several serious concerns regarding the use of Ct values. Importantly, Ct values can vary significantly among between- and within-run methods. The diagnostic performance of the cobas SARS-CoV-2 Duo is appropriate. It is a precise, accurate, and sensitive method for the detection of SARS-CoV-2 RNA and is comparable to two qualitative assays (the cobas SARS-CoV-2 and the Liat cobas SARS-CoV-2 and Inf A/B). In contrast, using the Ct value to estimate viral load is not reliable, and utilization of a quantitative detection test, such as the cobas SARS-CoV-2 Duo, to accurately measure the viral load is needed.
- Discussion
- 1
- 10.1016/j.cmi.2020.10.022
- Oct 24, 2020
- Clinical Microbiology and Infection
Management of bacteriological specimens of patients suffering from coronavirus disease 2019 (COVID-19)
- Discussion
- 111
- 10.4103/ijmr.ijmr_1029_20
- Feb 1, 2020
- Indian Journal of Medical Research
First isolation of SARS-CoV-2 from clinical samples in India.
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.
What is the difference between bacteria and viruses?
What is the function of the immune system?Can diabetes be passed down from one generation to the next?